Tag: Biotechnology

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive

Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start

Novo Nordisk CEO sees 15 million-patient opportunity in Medicare coverage for obesity drugs

Moderna says FDA refuses to review its application for experimental flu shot